Chirfi Guindo has been appointed executive vice president and head of global marketing, market access and customer innovation at US biotech major Biogen (Nasdaq: BIIB).
In this newly-created role, Mr Guindo will lead Biogen’s global functions of marketing and asset teams, market access and customer innovation. He will report to Michel Vounatsos, chief executive of Biogen, will be a member of the executive committee and will be based in Cambridge, Massachusetts. His appointment takes effect November 7, 2017.
Mr Guindo brings 27 years of experience in the global pharmaceutical industry and has held several leadership positions at US pharma giant Merck & Co (NYSE: MRK) (known as MSD outside Canada and the USA) in Canada, the USA, France, Africa and the Netherlands. He worked in several disciplines including finance, sales & marketing, general management and global strategy/product development in specialty, acute and hospital care. Most recently Mr Guindo was president and managing director of Merck Canada.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze